Cytosorbents Corp Annual Share-based Payment Arrangement, Expense in USD from 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cytosorbents Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2024.
  • Cytosorbents Corp Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $1.46M, a 15.1% decline year-over-year.
  • Cytosorbents Corp Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $3.8M, a 9.52% decline year-over-year.
  • Cytosorbents Corp annual Share-based Payment Arrangement, Expense for 2024 was $3.8M, a 9.52% decline from 2023.
  • Cytosorbents Corp annual Share-based Payment Arrangement, Expense for 2023 was $4.2M, a 22.7% increase from 2022.
  • Cytosorbents Corp annual Share-based Payment Arrangement, Expense for 2022 was $3.42M, a 14.8% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3.8M -$400K -9.52% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $4.2M +$776K +22.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $3.42M -$597K -14.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 $4.02M +$507K +14.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-15
2020 $3.51M +$1.85M +111% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 $1.67M -$2.77M -62.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
2018 $4.44M +$1.12M +33.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-09
2017 $3.31M +$557K +20.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-05
2016 $2.76M +$2.38M +622% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 $382K -$314K -45.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $696K +$239K +52.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
2013 $457K +$394K +624% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 $63.1K -$802K -92.7% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
2011 $866K Jan 1, 2011 Dec 31, 2011 10-K 2013-04-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.